Follow-The-Filings

Security · featured owners

IRWD

Ironwood Pharmaceuticals Inc. COM CL A Equity among managers we track

  • 1 exit

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0% Exit 0.00 pp 13,000 $46K hist

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $104.06M $74.88M $41.14M
Gross profit — — —
Gross margin — — —
Net income $45.71M $880,000 -$37.39M
Net margin * 43.9% 1.2% -90.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $233.29M $182.37M $274.18M
Total non-current assets * $237.78M $168.54M $122.72M
Total assets $471.07M $350.91M $396.9M
Total current liabilities $276.1M $38.85M $242.22M
Total non-current liabilities — — —
Total equity -$346.3M -$301.34M -$261.84M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $183.43M $103.55M $127.04M
Cash from investing -$1.03B -$142,000 -$34,000
Cash from financing $277.16M -$106.97M $216,000
Net change in cash -$565.78M -$3.6M $126.9M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders